Dysregulation of apoptosis in the cholangiopathies and cholangiocarcinoma

Seminars in Liver Disease

Volumn 18, Issue 2, 1998, Pages 177-185

  Celli, Adriane ^a   Que, Florencia G ^a  

^a MAYO CLINIC   (United States)

Author keywords

Bile duct epithelial cells; Cholangiocarcinoma; Cholangiocytes; Cholangiopathies; Ductopenia

Indexed keywords

APOPTOSIS; ARTICLE; BILE DUCT; BILE DUCT CARCINOMA; BILE DUCT DISEASE; BILE FLOW; CANCER RISK; HUMAN; PRIORITY JOURNAL;

EID: 0031902607     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007153     Document Type: Article

References (67)

1. Que FG, Gores GJ. Cell death by apoptosis: Basic concepts and disease relevance for the gastroenterologist. Gastroenterology 1996;110:1238-1243
2. Jones BA, Gores GJ. Physiology and pathophysiology of apoptosis in gastrointestinal epithelial cells. Am J Physiol 1997; 273(6pt1):1174-1188
3. Kuroki T, Seki S, Kawakita N, Nakatani K, Hisa T. Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis. Virchows Arch 1996;429:119-129
4. Hiramatsu N, Hayashi N, Katayama K, Mochizuki K, Kawanishi Y, Kasahara A, Fusamoto H, Kamada, T. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 1993;19:1354-1359
5. Bernuau D, Feldmann G, Degott C, Gisselbrecht C. Ultrastructural lesions of bile ducts in primary biliary cirrhosis. Human Pathol 1981;12:782-793
6. Krams SM, Egawa H, Quinn MB, Villanueva JC, Garcia-Kennedy R. Martinez OM. Apoptosis as a mechanism of cell death in liver allograft rejection. Transplantation 1995;59:621-625
7. Ortiz-Arduan A, Danoff TM, Kalluri R, Gonzalez-Cuadroda S, Karp SL, Elkon K, Egido J, Neilson EG. Regulation of Fas and Fas-ligand expression in cultured murine renal cells and in the kidney during endotoxemia. Am J Physiol 1996;271:F1193-F1201
8. Wong GHW, Kaspar RL, Zweiger G, Carlson C, Fong SE, Ehsani N, Vehar G. Strategies for manipulating apoptosis for cancer therapy with tumor necrosis factor and lymphotoxin. Cell Biochem 1996;60:56-60
9. Patel T, Gores GJ. Apoptosis and hepatobiliary disease. Hepatology 1995;21 1725-1741
10. Bedi A, Pasricha PH, Akhtar AJ, Barber JP, Bedi GC, Giardiello FM, Zehnbauer BA, Hamilton SR, Jones RJ. Inhibition of apoptosis during development of colorectal cancer. Cane Res 1995; 55:1811-1816
11. Nagata S. Apoptosis by death factor. Cell 1997;88:335-365
12. Que FG, Gores GJ, LaRusso NF. Development and inital application of an in vitro model of apoptosis in rodent cholangiocytes. Am J Physiol 1997;272:G106-G115
13. Reynolds JE, Jinfang L, Craig RW, Eastman A. Bcl-2 and Mcl-1 expression in Chinese hamster ovary cells (CHO) inhibits intracellular acidification and apoptosis induced by staurosporine Exper Cell Res 1996;225:430-436
14. Charlotte F, L'Hermine A, Martin N, Geleyn Y, Nollet M, Gaulard P, Zafrani ES. Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Am J Pathol 1994;144:460-465
15. Skopelitou A, Hadjiyannakis M, Alexopoulou V, Krikoni O, Kamina S, Agnantis N. Topographical immunohistochemical expression of bcl-2 protein in human liver lesions. Anticancer Res 1996;16:975-978
16. Muchmore SW, Sattler M, Liang H, et al. X-ray and NMR structure of human Bcl-x(L), an inhibitor of programmed cell death. Nature 1996;381:335-341
17. Kluck RM, Bossy-Wetzel E, Green DR, Ncwmeyer DD. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis [see comments]. Science 1997, 275:1132-1136
18. Searle J, Kerr JFR, Bishop CJ. Necrosis and apoptosis: Distinct modes of cell death with fundamentally different significance. Pathol Ann 1982;17:229-259
19. Searle J, Harmon BV, Bishop CJ, Kerr JFR. The significance of cell death by apoptosis in hepatobiliary disease. Gastroent Hepatol 1987;2:77-96
20. Roberts SK, Ludwig J, Larusso NF. The pathobiology of biliary epithelia. Gastroenterology 1997;112:269-279
21. Balisteri WF, Grand R, Hoofnagle JH, Suchy FJ, Ryckman FC, Perlmutter DH, Sokol RJ. Biliary atresia: Current concepts and research directions. Hepatology 1996;23:1682-1692
22. LaRusso NF, Weisner RH, Ludwig J, MacCarty RL. Primary sclerosing cholangitis. N Engl J Med 1984;310:899-903
23. Jablonowski H, HIV infection: Finding in liver and bile ducts. Bildgebung 1995;62:260-270
24. Chukwuma CS. A new opportunistic infection' Microsporidiosis. Revue du Praticien 1994;44:877-881
25. Hamour AA, Ronnington A, Hawthorne B, Wilkins EG. Successful treatment of AIDS-related cryptosporidial sclerosing cholangitis. AIDS 1993;7:1449-1451
26. Kline TJ, De las Morenas T, O'Brian M, Smith BF, Afdhal NH. Squamous metaplasia of extrahepatic biliary system in an AIDS patient with cryptosporidia and cholangitis. Dig Dis Sci 1993; 38:960-962
27. Levine SA, Jobin C, Sartor RB, LaRusso NF. Cryptosporidium is cytopathic for human biliary epithelial cells by an apoptotic process associated with cytokine production. Hepatology 1996; 24:246A
28. Koga H, Sakisaka S, Ohishi M, Sata M, Tanikawa K. Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis Hepatology 1997;25:1077-1084
29. Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S, Hengartner H, Goldstein P. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994;265:528-530
30. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462
31. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell S, Lynch D, Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 1995;181:71-77
32. Lowin B, Hahne M, Mattmann C, Tschopp J, Cytolytic T-cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature 1994;370:650-652
33. Patel T, Gores GJ. Inhibition of bile-salt-induced hepatocyte apoptosis by the antioxidant lazaroid U83836E. Toxicol APPL Pharmacol 1997;142:116-122
34. Matsuda M, Masutani H, Nakamura H, et al. Protectve activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells. J Immunol 1991;147:3837-3841
35. van den Dobbelsteen DJ, Nobel CSI, Schlegel J, et al. Rapid and specific efflux of reduced glutathione during apoptosis induced by anti-Fas/APO-1 antibody. Biol Chem 1996;271: 15420-15427
36. Deas O, Dumont C, Mollercau B, et al. Thiol-mediated inhibition of FAS and CD2 apoptotic signaling in activated human peripheral T cells. Int Immunol 1997;9:117-125
37. Buttke TM, Sandstrom PA. Redox regulation of programmed cell death in lymphocytes. Free Rad Res 1995;22:389-397
38. Parkin DM, Ohshima H, Srivatanakul P, Vatanasapt V. Cholangiocarcinoma. Epidemiology, mechanisms of carcinogenesis and prevention. Cane Epidemiol Biomarkers Prevention 1993;2:537-544
39. Carriaga MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer Suppl 1995;75:171-190
40. Green DR, McGahon A, Martin SJ. Regulation of apoptosis by oncogenes. Cell Biochem 1996;60:33-38
41. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319: 525-532
42. Kiba T, Tsuda H, Pairojkul C, Inoue S, Sugimura T, Hirohashi S. Mutations of the p53 supressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand. Molec Carcinog 1993;8:312-318
43. Tada M, Yokosuka O, Omata M. Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing. Cancer 1990;66:930-935
44. Lee JC, Lin PW, Lin YJ, Lai J, Yang HB, Lai MD. Analysis of K-ras gene mutations in periampullary cancers, gallbladder cancers and cholarigiocareinomas from paraffin-embedded tissue sections. Formo Med Assoc 1995;94:719-723
45. Kaklamanis L, Savage A, Mortensen N, et al Early expression of Bcl-2 protein in the adenoma-carcinoma sequence of colorectal neoplasia. Pathol 1996;179:10-14
46. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994;124:1-6
47. Reed J. Bcl-2: Prevention of apoptosis as a mechanism of drug resistance. Drug Resist Clin Oncol Hematol 1995;9:451-473
48. Harnois DM, Que FG, Celli A, LaRusso NF, Gores GG. Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangicarcinoma cell line Hepatology 1997;26(4):884-890
49. Scarpa A, Capelli P, Zamboni G, et al. Neoplasia of the ampulla of Vater: Ki-ras and p-53 mutations. Am J Pathol 1993;142: 1163-1172
50. Lane DP. p53. guardian of the genome. Nature 1992;358:15-16
51. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;74:957-967
52. Ohashi K, Nakajima Y, Kanehiro H, et al. K-ras mutations and p-53 protein expressions in intrahepatic cholangiocarcinomas: Relation to gross tumor morphology. Gastroenterology 1995;109: 1612-1617
53. Chen YC, Faller DV. Direction of p21ras-generated signals towards cell growth or apoptosis is determined by protein kinase C and Bcl-2. Oncogene 1995;11:1487-1498
54. Tsutsumi M, Murakami Y, Kondoh S, et al Comparison of K-ras oncogene activation in pancreatic duct carcinomas and cholangiocarcinomas induced in hamsters by n-nitrosobis(2-hydroxypropyl)amine. Japan J Cane Res 1993;84:956-960
55. Levi S, Urbano-Ispizua A, Gill R, Thomas DM, Gilbertson J, Foster C, Marshall CJ. Multiple K-ras codon mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique Cane Res 1991;51:3497-3502
56. Garewal H, Bernstein H, Bernstein C, Sampliner R, Payne C, Reduced bile acid-induced apoptosis in "normal" colorectal mucosa: A potential biological marker for cancer risk. Cane Res 1996;65:1480-1483
57. Herzenberg LA, De Rosa SC, Dubs JG, et al. Glutathione deficiency is associated with impaired survival in HIV disease. Proced Nat Acad Sci 1997;94:1967-1972
58. Deleve LD, Kaplowitz N. Importance and regulation of hepatic glutathione. Sem Liver Dis 1990;10:251-266
59. Ballatori N, Jacob R, Barret C, Boyer JL. Biliary catabolism of glutathione and differential reabsorption of its amino acid constituents. Am J Physiol 1988;254:G1-G7
60. Ballatori N, Jacob R, Boyer JL. Intrabiliary glutathione hydroly-sis. J Biol Chem 1996;17:7860-7865
61. Watson RW, Rotstein OD, Nathens AB, Dackiw AP, Marshall JC. Thiol-mediated redox regulation of neutrophil apoptosis. Surgery 1996;120:150-158
62. Janssen YM, Van Houten B, Borm PJ, Mossman BT. Cell and tissue responses to oxidative damage. Lab Invest 1993;69: 261-274
63. Aniya Y, Teruya M. Activation of microsomal glutathione S-transferase of rats by a glutathione depletor. diethylmaleate. J Pharmacobio-Dynamics 1992;15:473-479
64. Scholz M, Cinatl J, Gross V, et al. Impact of oxidative stress on human cytomegalovirus replication and on cytokine-mediated stimulation of endothelial cells. Transplantation 1996;61:1763-1770
65. Miesel R, Sanocka D, Kurpisz M, Kroger H. Antiinflammatory effects of NADPH oxidase inhibitors. Inflammation 1995;19: 347-362
66. Proulx M, du Souich P. Inflammation-induced decrease in hepatic cytochrome P450 in conscious rabbits is accompanied by an increase in hepatic oxidative stress. Res Comm Molec Pathol Pharmacol 1995;87:221-236
67. Takikawa H, Wako Y, Sano N, Yamanaka M Changes in biliary excretory mechanisms in bile duct-ligated rats. Dig Dis Sci 1996;41:256-262